At data cut-off, 44 consecutive BRAF mutant advanced NSCLC patients were included and the proportion of cases harboring BRAF V600E alteration resulted in 52.2%, consistent with other reported observations [10,11,12,21]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.